MOTS-C
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded by the mitochondrial genome. It has drawn major research interest because it appears to regulate metabolic homeostasis, skeletal muscle signaling, and stress responses in preclinical models. The strongest evidence for benefits such as improved insulin sensitivity, exercise-mimetic effects, and healthier aging comes mainly from animal and mechanistic studies, not established human clinical use.
Overview
MOTS-C belongs to a small family of mitochondrial-derived peptides. Reviews describe it as a signaling peptide that links mitochondrial function to nuclear and metabolic responses, especially under stress, exercise, and nutrient-challenge conditions. It has been studied in obesity, insulin resistance, muscle aging, cardiovascular models, and inflammation-related research, but clinical translation is still early.
What it is
MOTS-C is a mitochondrial-encoded 16-amino-acid peptide. USADA describes it as coded by the mitochondrial genome, and review literature places it among the known mitochondrial-derived peptides involved in energy and stress biology.
Mechanism (high level)
MOTS-C is thought to influence metabolism through pathways tied to AMPK activation, skeletal muscle metabolic regulation, stress adaptation, and mitochondria-to-nucleus signaling. Review and preclinical sources describe it as helping regulate glucose handling, insulin sensitivity, and exercise-related metabolic responses, though these mechanisms are much better established in models than in therapeutic human use.
Quick facts
- Dosage
- There is no universally accepted evidence-based human dose for MOTS-C. FDA says it has not identified human exposure data for drug products containing MOTS-C administered by any route.
- Route
- No standardized evidence-based human route has been established for drug use. FDA says it has not identified human exposure data for MOTS-C by any route of administration.
- Cycle
- No standardized cycle has been established in humans.
- Storage
- Follow manufacturer or compounding-pharmacy instructions exactly Protect from heat and light Do not use beyond labeled storage limits Because there is no approved standardized MOTS-C drug product, storage should follow the exact dispensing source, not a generic rule.
Research indications
- Metabolic homeostasis research
- Insulin sensitivity research
- Obesity research
- Skeletal muscle metabolism research
- Exercise-mimetic research
- Healthy aging research
- Cardiometabolic research
- Mitochondrial stress-response research
Research protocols (education)
Most published efficacy data are from animal and cell studies Human studies more commonly measure circulating MOTS-C levels than administer MOTS-C as a drug No standardized therapeutic human protocol is established in peer-reviewed literature Exercise studies suggest endogenous MOTS-C levels can rise with exercise in humans
That framing is the most evidence-based. FDA says there are no human exposure data for MOTS-C drug products, while USADA notes exercise raises MOTS-C levels in humans and the performance data come largely from mice.
Interactions
Often avoided with
- Unsupervised use of compounded MOTS-C
- Use in competitive athletes subject to anti-doping rules
- Use when product source or sterility is uncertain
- Pregnancy unless clinician supervised
- Breastfeeding unless clinician supervised
- Use with caution in people relying on proven therapy for obesity, diabetes, or metabolic disease
Often combined with
- Clinician-supervised investigational discussion
- Review of preclinical metabolic research
- Use only with clear understanding that it is non-approved
- Use only with verified sourcing and oversight
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- No established human safety profile
- Potential immunogenicity risk
- Potential peptide-related impurity risk
- Potential API characterization complexity
- Long-term human safety unknown
- Product quality may vary across non-standardized sources
Regulatory notes
- Not an FDA-approved drug
- FDA says compounded MOTS-C may pose significant safety risk
- FDA has not identified human exposure data for MOTS-C drug products by any route
- Not a legitimate dietary ingredient
- Prohibited in sport under anti-doping rules
FAQ
What is MOTS-C?
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded by the mitochondrial genome and studied for roles in metabolism, exercise signaling, and cellular stress responses.
Is MOTS-C FDA approved?
No. MOTS-C is not FDA-approved for use in humans, and FDA says compounded MOTS-C may pose significant safety risks.
What is MOTS-C used for?
It is mainly studied for metabolic homeostasis, insulin sensitivity, obesity, muscle metabolism, and healthy-aging research. These are investigational research areas, not approved indications.
Is MOTS-C banned in sports?
Yes. USADA says MOTS-C is prohibited at all times under the WADA Prohibited List as an AMPK activator.
Does MOTS-C have strong human evidence?
No. Current evidence is driven mainly by animal, mechanistic, and observational human data rather than an established body of completed therapeutic human trials. FDA says it has not identified human exposure data for MOTS-C drug products.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.